Two studies on the genome of the coronavirus in India conducted by the country’s top clinical research body and the Department of Bio-Technology suggest that the COVID-19 virus is genetically stable and has shown no major mutation, the Prime Minister’s office said on Saturday.
There had been some concern that any major mutation detected in the novel coronavirus could affect the development of an effective vaccine. However, some recent global studies have said the vaccines currently being developed for COVID-19 should not be affected by these mutations.
Mutation typically refers to the property of a virus to change when it multiplies and the virus may develop some new strains after it replicates. In cases, the new strains tend to be less effective and therefore die out soon, while more powerful strains may lead to faster spread of the virus.
After a review meeting chaired by Prime Minister Narendra Modi on the COVID-19 pandemic situation, and vaccine delivery, distribution and administration preparedness, the Prime Minister’s Office said in a statement that three vaccines are in advanced stages of development in India, out of which two are in Phase II and one is in Phase-III.
- Coffee, Green Tea Might Extend Life for Folks With Type 2 Diabetes - October 24, 2020
- Europe, WHO sound alarm over resurgent virus crisis - October 24, 2020
- Covid-19 Vaccine: India Gives Approval To Start Phase Three Clinical Trials - October 24, 2020
- US suicide rate fell last year after decade of steady rise - October 24, 2020
- Depression औऱ Migrane के लिए करें ये आसन… -जल्द मिलेगी राहत | Baba Ramdev Yog Yatra - October 24, 2020
- New population of immune cells could play a role in multiple sclerosis - October 24, 2020
- MEDREICH LIMITED Urgent Requirements for QA QC Technology Transfer R and D Departments Apply Now - October 24, 2020
- RECKON Diagnostics Urgent Openings for Freshers and Experienced in QA R and D Production Finance Distribution Administration Departments Apply Now - October 24, 2020
- Mankind Pharma Ltd Mega Walk In Drive for Multiple Openings in Quality Assurance Quality Control Microbiology Departments on 1st Nov 2020 - October 24, 2020
- Vaccine Trials Should Not Be Stopped Even In The Event Of Death, Scientists Have Said | वैज्ञानिकों ने कहा - October 24, 2020